Added receptor helps CAR T cells stay in bone marrow in cancer mouse models

The Quick Take
By turning a patient's own immune cells into stronger cancer-fighting cells, CAR T-cell therapy has transformed how some blood cancers are treated. But it's been harder to extend this approach to solid tumors, including cancer that has spread to the bone.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Phys.org.



